Recent network meta-analyses identified the relative outcomes of various vitiligo monotherapies on vitiligo at 6 months.

It should be noted that while clobetasol propionate was chosen because it was considered the most effective topical glucocorticoid therapy for vitiligo, this study compared its cream formulation ...

While vitiligo can affect any area of the body ... Though none of these treatments really had an impact. At 14, she used an ointment recommended to her by a Turkish doctor, which to our shock ...

Incyte has made further progress with its ruxolitinib cream, notching up a phase 3 trial showing it can re-pigment skin in vitiligo ahead of a key FDA decision in atopic dermatitis.

Lopez said the new cream, Opzelura, that came out two years ago has changed that. “About two-thirds of patients are seeing at least 75% improvement in the vitiligo on the face, and that’s just ...

Results in vitiligo came from the TRuE-V1 and TRuE-V2 studies, which showed that around 30% of patients treated with ruxolitinib cream twice daily achieved 75% or more improvement from baseline in ...